EasyChamber is an anti-static valve holding chamber for Metered-Dose Inhalers which comes in four variants to suite for all Patient Group. Unlike other spacer device, EasyChamber comes with a detachable mask which enables patient to use the spacer with or without mask.
- EasyChamber Spacer costs approximately 25% less than other available anti-static spacers in the UK market.
- Every year the NHS spends more than £12m on inhaler spacers. By switching to EasyChamber, the NHS can save up to £2.5m a year just in primary care.1
- Prescribing EasyChamber Spacer by the brand is the least expensive way of prescribing inhaler spacers for pMDI.
| Product | EasyChamber® Drug Tariff Price* |
Other Leading Brand* | Saving with EasyChamber Spacer |
|---|---|---|---|
| EasyChamber Spacer(Mouthpiece) |
£ 3.98 | £ 5.22 | 23.75% |
| EasyChamber Spacer with Infant Mask |
£ 6.53 | £ 8.72 | 25.11% |
| EasyChamber Spacer with Child Mask |
£ 6.55 | £ 8.72 | 24.88% |
| EasyChamber Spacer with Adult Mask |
£ 6.59 | £ 8.72 | 24.42% |
1:NHS PCA Data
Features & Benefits
- Maximises the aerosol suspension time and assure a more efficient dose from the MDI with an anti-static chamber.
- Latex-free, anatomical and comfortable silicon mask with variants for Adult, Child & Infant
- Detachable silicone mask that offers flexibility to use spacer without a mask, if required.
- The inhalation through cross valves ensures low resistance when breathing in and prevents accidental breathing out into the chamber.
- Improved drug delivery and ease of use due to one-way inhalation.
- FlowSignal whistle indicator sounds when breathing in too fast, encourages the patient to breathe slowly.
- Compact and comes with an outer box for easy storage.
Evidence of Use
- The spacer device reduces the velocity of the aerosol and the subsequent impact on the oropharynx, allows more time for evaporation of the propellant so that a larger proportion of the particles can be inhaled and deposited in the lungs.
- Spacer Chamber improves drug delivery.
- The spacer device is useful for patients with poor inhalation technique, for children, for patients requiring higher doses of inhaled corticosteroids, for nocturnal asthma, for patients with coordination problems and for patients prone to oral candidiasis with inhaled corticosteroids.1-2
2.http://www.medicinescomplete.com/mc/bnf/cu rent/PHP18646-a2a-spacer.htm?q=spacat&t=search&sa=text p=1#PHP18646-a2a-spacer
3.Dr Tristan Learoyd, Senior Lecturer, Respiratory Education UK: www.respiratoryeduk.com
EasyChamber® has been evaluated in a series of published scientific studies assessing aerosol delivery performance under a range of simulated use conditions.
| Publication | Study Title | EasyChamber® Model | Journal | Peer Review | Study Type |
|---|---|---|---|---|---|
| May-26 | In vitro Performance of Valved Holding Chambers in Paediatric Asthma Controller Therapy | Model 3 (Current) |
Acta Paediatrica | Peer-reviewed | Independent |
| Apr-26 | In vitro characterisation of fluticasone propionate and ciclesonide delivered with and without valved holding chambers using cascade impaction and an adult simulated breathing profile | Model 3 (Current) |
BMJ Open Respiratory Research | Peer-reviewed | Independent |
| Aug-25 | Inhaled salbutamol delivery in small children with disposable and reusable spacers: an in vitro study | Model 3 (Current) |
Archives of Disease in Childhood | Peer-reviewed | Independent |
| Jul-25 | The effect of inhalation delay on the aerodynamic particle size distribution of fluticasone propionate and ciclesonide using pMDI and valved holding chambers | Model 3 (Current) |
Respiratory Medicine | Peer-reviewed | Independent |
| Sep-24 | Inhaled corticosteroid delivery is markedly affected by breathing pattern and valved holding chamber model | Model 3 (Current) |
Pediatric Pulmonology Wiley | Peer-reviewed | Independent |
TriOn no longer relies on the results of an emitted dose comparison bench study between EasyChamber Spacers VHCs and AeroChamber Plus Flow-Vu Spacers which was conducted in April 2022 by an independent laboratory engaged by Trion and which were circulated by TriOn in EasyChamber marketing materials. This is because the extent of the tests which TriOn itself directed the laboratory to carry out were too limited in scope which impacted the robustness and dependability of the test results, including those pertaining to the AeroChamber Plus Flow-Vu Spacers.
We recognise the importance of the continued supply of branded medicines/devices and are committed to maintaining the highest quality standards, ensuring that stock is available to the NHS across all parts of the UK. Our experienced team have a proven track record of over 15 years supplying medicines and devices to both primary and secondary care organisations across the UK.
We are therefore committed to ensuring sustainable supply. For further information, please contact us at info@trionpharma.co.uk
If you require this QR code for your clinic, please click the download button below to obtain it.
